科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/09/03 | 4,025 | 4,051 | 4,000 | 4,038 | +26 | +0.6% | 67,700 |
| 2024/09/02 | 4,128 | 4,128 | 4,009 | 4,012 | -116 | -2.8% | 111,900 |
| 2024/08/30 | 4,108 | 4,130 | 4,078 | 4,128 | +28 | +0.7% | 184,400 |
| 2024/08/29 | 4,119 | 4,141 | 4,074 | 4,100 | -13 | -0.3% | 95,100 |
| 2024/08/28 | 4,111 | 4,124 | 4,088 | 4,113 | +5 | +0.1% | 88,300 |
| 2024/08/27 | 4,087 | 4,112 | 4,083 | 4,108 | +41 | +1% | 83,100 |
| 2024/08/26 | 4,095 | 4,099 | 4,049 | 4,067 | -46 | -1.1% | 82,600 |
| 2024/08/23 | 4,110 | 4,135 | 4,098 | 4,113 | +12 | +0.3% | 105,500 |
| 2024/08/22 | 4,100 | 4,154 | 4,090 | 4,101 | +5 | +0.1% | 112,700 |
| 2024/08/21 | 3,970 | 4,100 | 3,934 | 4,096 | +119 | +3% | 180,900 |
| 2024/08/20 | 3,971 | 3,989 | 3,942 | 3,977 | +58 | +1.5% | 133,000 |
| 2024/08/19 | 3,974 | 3,974 | 3,900 | 3,919 | -32 | -0.8% | 80,400 |
| 2024/08/16 | 3,920 | 3,952 | 3,884 | 3,951 | +72 | +1.9% | 131,600 |
| 2024/08/15 | 3,944 | 3,944 | 3,855 | 3,879 | -28 | -0.7% | 105,900 |
| 2024/08/14 | 3,841 | 3,928 | 3,821 | 3,907 | +66 | +1.7% | 118,600 |
| 2024/08/13 | 3,870 | 3,870 | 3,809 | 3,841 | -41 | -1.1% | 136,300 |
| 2024/08/09 | 3,930 | 3,930 | 3,795 | 3,882 | +22 | +0.6% | 156,100 |
| 2024/08/08 | 3,705 | 3,899 | 3,676 | 3,860 | +15 | +0.4% | 295,400 |
| 2024/08/07 | 3,742 | 4,099 | 3,725 | 3,845 | +64 | +1.7% | 333,200 |
| 2024/08/06 | 3,794 | 3,803 | 3,706 | 3,781 | +197 | +5.5% | 232,500 |
| 2024/08/05 | 3,750 | 3,813 | 3,554 | 3,584 | -261 | -6.8% | 338,500 |
| 2024/08/02 | 3,955 | 3,967 | 3,812 | 3,845 | -169 | -4.2% | 177,900 |
| 2024/08/01 | 4,073 | 4,079 | 3,997 | 4,014 | -71 | -1.7% | 123,500 |
| 2024/07/31 | 4,082 | 4,111 | 4,037 | 4,085 | +43 | +1.1% | 343,400 |
| 2024/07/30 | 4,099 | 4,117 | 4,026 | 4,042 | -34 | -0.8% | 118,300 |
| 2024/07/29 | 4,097 | 4,125 | 4,072 | 4,076 | +11 | +0.3% | 86,800 |
| 2024/07/26 | 4,061 | 4,093 | 4,033 | 4,065 | +14 | +0.3% | 112,300 |
| 2024/07/25 | 4,000 | 4,063 | 3,981 | 4,051 | +30 | +0.7% | 122,100 |
| 2024/07/24 | 4,038 | 4,081 | 4,013 | 4,021 | -7 | -0.2% | 85,500 |
| 2024/07/23 | 4,010 | 4,038 | 3,980 | 4,028 | -10 | -0.2% | 120,300 |
| 2024/07/22 | 4,116 | 4,117 | 4,023 | 4,038 | -57 | -1.4% | 102,800 |
| 2024/07/19 | 4,157 | 4,157 | 4,059 | 4,095 | -91 | -2.2% | 146,400 |
| 2024/07/18 | 4,102 | 4,217 | 4,088 | 4,186 | +112 | +2.7% | 235,500 |
| 2024/07/17 | 4,086 | 4,111 | 4,074 | 4,074 | -5 | -0.1% | 103,100 |
| 2024/07/16 | 4,100 | 4,149 | 4,075 | 4,079 | +21 | +0.5% | 149,000 |
| 2024/07/12 | 3,995 | 4,073 | 3,995 | 4,058 | +46 | +1.1% | 137,700 |
| 2024/07/11 | 3,980 | 4,013 | 3,977 | 4,012 | +52 | +1.3% | 99,700 |
| 2024/07/10 | 3,967 | 3,987 | 3,940 | 3,960 | +1 | ±0% | 125,600 |
| 2024/07/09 | 3,950 | 3,994 | 3,950 | 3,959 | +15 | +0.4% | 107,600 |
| 2024/07/08 | 3,950 | 4,059 | 3,929 | 3,944 | +16 | +0.4% | 207,700 |
| 2024/07/05 | 3,899 | 3,928 | 3,883 | 3,928 | +42 | +1.1% | 114,300 |
| 2024/07/04 | 3,863 | 3,922 | 3,850 | 3,886 | +22 | +0.6% | 114,700 |
| 2024/07/03 | 3,817 | 3,878 | 3,802 | 3,864 | +43 | +1.1% | 120,100 |
| 2024/07/02 | 3,854 | 3,866 | 3,809 | 3,821 | -34 | -0.9% | 133,900 |
| 2024/07/01 | 3,845 | 3,900 | 3,842 | 3,855 | +5 | +0.1% | 147,800 |
| 2024/06/28 | 3,858 | 3,879 | 3,811 | 3,850 | +4 | +0.1% | 165,900 |
| 2024/06/27 | 3,830 | 3,881 | 3,811 | 3,846 | +22 | +0.6% | 210,900 |
| 2024/06/26 | 3,798 | 3,829 | 3,786 | 3,824 | +24 | +0.6% | 111,200 |
| 2024/06/25 | 3,800 | 3,830 | 3,794 | 3,800 | +9 | +0.2% | 86,400 |
| 2024/06/24 | 3,779 | 3,812 | 3,778 | 3,791 | +13 | +0.3% | 137,000 |
201～
250
件表示中 / 3732件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 379,100円 | -6.4% | -71.8% | 5.01% | 42.34倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 鳥居薬 | 632,000円 | +7.1% | -35.0% | 0.00% | 52.26倍 | 1.46倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| サンバイオ | 233,200円 | - | - | 0.00% | - | 111.58倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ジーエヌアイ | 330,000円 | +21.7% | +999.9% | 0.00% | 13.83倍 | 4.76倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 東和薬品 | 299,700円 | +7.9% | -3.3% | 2.67% | 8.34倍 | 0.86倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
